Financial Gravity Asset Management’s Editas Medicine EDIT Stock Holding History

Financial Gravity Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8	Closed	-$9	–	1397
2023 Q2	$9	Buy	+8	New	+$70	﹤0.01%	1549
2023 Q1	–	Sell	-9	Closed	-$9	–	1294
2022 Q4	$9	Buy	+9	New	+$99	﹤0.01%	1371
2022 Q2	–	Sell	-19	Closed	-$1	–	764
2022 Q1	$1	Sell	19 -8	-30%	-$149	﹤0.01%	882
2021 Q4	$3	Buy	+27	New	+$929	﹤0.01%	917
2021 Q3	–	Hold	0	–	–	–	637
2021 Q2	–	Hold	0	–	–	–	524

Other funds holding EDIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Gravity Asset Management's EDIT Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 8 shares — an estimated $9 sold.

Financial Gravity Asset Management first reported a position in EDIT in Q4 2021 and held it in 4 quarters. The position peaked at $9 in Q2 2023. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

Financial Gravity Asset Management reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
Financial Gravity Asset Management sold 8 Editas Medicine shares in Q3 2023, an estimated $9.
Financial Gravity Asset Management first reported a position in Editas Medicine in Q4 2021 and held it in 4 quarters.
Financial Gravity Asset Management's Editas Medicine position peaked at $9 in Q2 2023.
220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.